2023-12-15 10:10:21 International news 15 Dec. 2023 4:33 p.m. 2023-12-15 The White House said Thursday (Dec. 14) that Sanofi and AstraZeneca (AstraZeneca) plans to deliver an additional 230,000 doses of respiratory syncytial virus (RSV) vaccine to infants in January. 2024 after US officials held discussions with both companies about winter vaccine delivery. Sanofi said in … Read more
2023-12-12 09:16:48 She is still talked about. The Sanofi factory in Mourenx (Pyrénées-Atlantiques), which produces the drug Dépakine, released quantities of bromopropane more than 75 times higher than the authorized threshold, in mid-November, we learned on Monday from consistent sources, confirming a log information The world. On December 6, company representatives in Mourenx informed the … Read more
2023-12-01 08:00:00 Dupixent effective against BCPO Sanofi released new data on its blockbuster drug Dupicent (dupilumab), evaluated in a second phase III trial against chronic obstructive pulmonary disease (COPD). These results confirm those of the first study, with a 34% reduction in disease exacerbations. As a result, filing a Supplemental Biologics License Application (sBLA) with … Read more
2023-11-07 11:07:00 The French pharmaceutical group Sanofi is under investigation by the National Financial Prosecutor’s Office (PNF) for price manipulation and dissemination of false or misleading information in its financial communication around its flagship drug, Dupixent. The information, revealed on Tuesday November 7 by the investigative media La Lettre, was confirmed by a judicial source … Read more
2023-10-27 10:40:19 Sanofi will separate its Consumer Health division (Doliprane, Mucosolvan, etc.) by listing it separately on the stock market in 2024 to focus on new growth drivers in innovative medicines that it wants to finance through a savings plan. The French pharmaceutical giant has decided to make Consumer Health “an autonomous global commercial entity … Read more
2023-10-27 07:00:00 European Marketing Authorization for Enhertu L’get stronger (trastuzumab deruxtecan) developed by AstraZeneca et Daiichi Sankyo has just obtained European Marketing Authorization. This ADC (antibody drug conjugate) is now authorized as monotherapy in Europe, for patients suffering from metastatic non-small cell lung cancer with HER2 mutation and treated with at least one line of … Read more
2023-07-11 09:14:00 MERIDA. pharmaceutical company Sanofi introduced Dupilumabthe only biological medicine available in Mexico to treat moderate to severe cases of Atopic dermatitis (AD) in the pediatric populationfrom six months, and Asthma in children from six years. Atopic Dermatitis and Asthma are type 2 inflammatory diseases, in which interleukin-4 and interleukin-13 are key drivers of … Read more
There have been lawsuits in the US about the drug Zantac for quite some time. According to the plaintiffs, this should probably be responsible for the development of cancer. At least in one state, the disputes will not be carried out in court. A judge in Florida recently put a stop to that. For Robin … Read more